Item 8.01. Other Events.
On May 1, 2009, VIA Pharmaceuticals, Inc. (the "Company") issued a press release announcing results of a sub-study of patients from the Company's acute coronary syndrome Phase 2 clinical trial of its lead drug candidate, VIA-2291. The results were presented on May 1, 2009 at the American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009 in Washington, D.C.
A copy of the press release is filed as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.

Exhibit No Description
99.1 Press Release dated May 1, 2009

---